INVO Bioscience Inc
NASDAQ:INVO
INVO Bioscience Inc
EPS (Diluted)
INVO Bioscience Inc
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
INVO Bioscience Inc
NASDAQ:INVO
|
EPS (Diluted)
-$5
|
CAGR 3-Years
45%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
EPS (Diluted)
$4
|
CAGR 3-Years
-7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-1%
|
|
Boston Scientific Corp
NYSE:BSX
|
EPS (Diluted)
$1
|
CAGR 3-Years
105%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
16%
|
|
Stryker Corp
NYSE:SYK
|
EPS (Diluted)
$8
|
CAGR 3-Years
33%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
16%
|
|
Abbott Laboratories
NYSE:ABT
|
EPS (Diluted)
$3
|
CAGR 3-Years
0%
|
CAGR 5-Years
17%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
EPS (Diluted)
$5
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
14%
|
See Also
What is INVO Bioscience Inc's EPS (Diluted)?
EPS (Diluted)
-5.1
USD
Based on the financial report for Dec 31, 2023, INVO Bioscience Inc's EPS (Diluted) amounts to -5.1 USD.
What is INVO Bioscience Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
17%
Over the last year, the EPS (Diluted) growth was 71%. The average annual EPS (Diluted) growth rates for INVO Bioscience Inc have been 45% over the past three years , 17% over the past five years .